Seminar: Aβ Immunotherapy for the treatment of Alzheimer´s Disease
On Monday, 13th of August at 1pm, Matthias Staufenbiel, PhD, Director at the Novartis Institutes for BioMedical Research Basel, Switzerland will give a seminar on“Aβ Immunotherapy for the treatment of Alzheimer´s Disease”.
The presentation will summarize studies of the active Aβ immunotherapeutic CAD106, which is currently in clinical development (Phase II). In addition, experiments will be discussed addressing general mechanistic questions of Aβ immunotherapy.
Where: The Library at the Aschheim Zondek-Haus (room 02 001)
Virchowweg 21, 10117 Berlin.
